Naya Biosciences, Stock Fundamentals
| NAYA Stock | 0.37 0.01 2.63% |
NAYA Biosciences, fundamentals help investors to digest information that contributes to NAYA Biosciences,'s financial success or failures. It also enables traders to predict the movement of NAYA Stock. The fundamental analysis module provides a way to measure NAYA Biosciences,'s intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to NAYA Biosciences, stock.
At present, NAYA Biosciences,'s Tax Provision is projected to increase significantly based on the last few years of reporting. The current year's Interest Expense is expected to grow to about 1 M, whereas Net Interest Income is forecasted to decline to (1.1 M).
NAYA | Select Account or Indicator |
NAYA Biosciences, Company Current Valuation Analysis
NAYA Biosciences,'s Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current NAYA Biosciences, Current Valuation | 14.07 M |
Most of NAYA Biosciences,'s fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, NAYA Biosciences, is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, NAYA Biosciences, has a Current Valuation of 14.07 M. This is 99.9% lower than that of the Healthcare sector and 99.89% lower than that of the Medical Devices industry. The current valuation for all United States stocks is 99.92% higher than that of the company.
NAYA Biosciences, Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining NAYA Biosciences,'s current stock value. Our valuation model uses many indicators to compare NAYA Biosciences, value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across NAYA Biosciences, competition to find correlations between indicators driving NAYA Biosciences,'s intrinsic value. More Info.NAYA Biosciences, is rated top company in current valuation category among its peers. It also is considered to be number one stock in shares outstanding category among its peers creating about 0.32 of Shares Outstanding per Current Valuation. The ratio of Current Valuation to Shares Outstanding for NAYA Biosciences, is roughly 3.14 . As of March 2, 2025, Common Stock Shares Outstanding is expected to decline to about 2.4 M. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the NAYA Biosciences,'s earnings, one of the primary drivers of an investment's value.NAYA Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses NAYA Biosciences,'s direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of NAYA Biosciences, could also be used in its relative valuation, which is a method of valuing NAYA Biosciences, by comparing valuation metrics of similar companies.NAYA Biosciences, is currently under evaluation in current valuation category among its peers.
NAYA Biosciences, Current Valuation Drivers
We derive many important indicators used in calculating different scores of NAYA Biosciences, from analyzing NAYA Biosciences,'s financial statements. These drivers represent accounts that assess NAYA Biosciences,'s ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of NAYA Biosciences,'s important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 760.9K | 1.5M | 1.7M | 2.2M | 2.0M | 2.1M | |
| Enterprise Value | (8.6M) | (2.1M) | 3.9M | 8.2M | 7.4M | 7.8M |
NAYA Fundamentals
| Current Valuation | 14.07 M | ||||
| Shares Outstanding | 4.48 M | ||||
| Shares Owned By Insiders | 15.56 % | ||||
| Shares Owned By Institutions | 2.88 % | ||||
| Number Of Shares Shorted | 72.18 K | ||||
| Price To Book | 5.97 X | ||||
| Price To Sales | 0.18 X | ||||
| Revenue | 3.02 M | ||||
| EBITDA | (6.88 M) | ||||
| Net Income | (8.03 M) | ||||
| Total Debt | 6.3 M | ||||
| Book Value Per Share | (3.91) X | ||||
| Cash Flow From Operations | (4.76 M) | ||||
| Short Ratio | 0.78 X | ||||
| Earnings Per Share | (1.01) X | ||||
| Target Price | 2.0 | ||||
| Market Capitalization | 2.48 M | ||||
| Total Asset | 18.51 M | ||||
| Retained Earnings | (57.82 M) | ||||
| Working Capital | (6.74 M) | ||||
| Net Asset | 18.51 M |
About NAYA Biosciences, Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze NAYA Biosciences,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NAYA Biosciences, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NAYA Biosciences, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 367.9 K | 249.8 K | |
| Total Revenue | 3.5 M | 2.5 M | |
| Cost Of Revenue | 2.2 M | 2.3 M | |
| Stock Based Compensation To Revenue | 0.53 | 0.50 | |
| Research And Ddevelopement To Revenue | 0.06 | 0.06 | |
| Capex To Revenue | 0.17 | 0.19 | |
| Revenue Per Share | 0.87 | 0.48 | |
| Ebit Per Revenue | (2.02) | (2.12) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether NAYA Biosciences, offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NAYA Biosciences,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Naya Biosciences, Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Naya Biosciences, Stock:Check out NAYA Biosciences, Piotroski F Score and NAYA Biosciences, Altman Z Score analysis. For information on how to trade NAYA Stock refer to our How to Trade NAYA Stock guide.You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Medical Equipment space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NAYA Biosciences,. If investors know NAYA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NAYA Biosciences, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.01) |
The market value of NAYA Biosciences, is measured differently than its book value, which is the value of NAYA that is recorded on the company's balance sheet. Investors also form their own opinion of NAYA Biosciences,'s value that differs from its market value or its book value, called intrinsic value, which is NAYA Biosciences,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NAYA Biosciences,'s market value can be influenced by many factors that don't directly affect NAYA Biosciences,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NAYA Biosciences,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if NAYA Biosciences, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NAYA Biosciences,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.